Organ Dysfunction Changes in Acute Necrotizing Pancreatitis Patients With Sepsis Following Open Necrosectomy

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWest China Hospital

About this trial

The purpose of this retrospective study was to characterize the changes in organ dysfunction among patients with acute necrotizing pancreatitis complicated by sepsis who underwent open necrosectomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients 18 years or older

Diagnosis of Acute pancreatitis according to the revised Atlanta classification, requires two of thefollowing three criteria: (A) typical abdominal pain, (B) an increase in serum amylase or lipaselevels higher than three times the upper limit of normality, and (C) signs of AP in imaging3)Patients with confirmed or suspected infected pancreatic or peripancreatic necrosis werescheduled for open necrosectomy

Meet Sepsis-3 criteria

Disqualifiers

None

Trial population

This retrospective cohort included patients with acute necrotizing pancreatitis complicated by sepsis who underwent open necrosectomy

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Necrotizing Pancreatitis patients' organdysfunction progression

    Other intervention

    Study the dynamic nature of organ dysfunction

Treatment groups

700 Participants
are divided into 1 treatment group
Group A: Pancreatitis with sepsis patients' organdysfunction progression after opennecrosectomy1 intervention

Trial outcomes

Primary outcomes

1

Measure organ dysfunction change after open necrosectomy with respect to time

Organ dysfunction was assessed retrospectively using the Sequential Organ Failure Assessment (SOFA) score, which ranges from 0 (normal) to 4 (most abnormal) for each organ, with higher scores indicating more severe dysfunction.

Time frame
up to postoperative day 7, or at hospital discharge, whichever comes first

Secondary outcomes

1

Incidence of ICU mortality

Time frame
an average of 1year
2

Incidence of hospital mortality

Time frame
an average of 1 year
3

Incidence of 28-day mortality

Time frame
an average of 1 year
4

Incidence of one year mortality

Time frame
an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: